Andre Ghetti

Human-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshop.

Human ex-vivo action potential model for pro-arrhythmia risk assessment.

Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk.

Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae.

Label-free imaging of atherosclerotic plaques using third-harmonic generation microscopy.

The West coast regional safety pharmacology society meeting update: Filling translational gaps in safety assessment.

Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity.

Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.

Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes.

Discovery and characterization of ORM-11372, a novel inhibitor of the sodium-calcium exchanger with positive inotropic activity.

Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes.

Human cells and networks of pain: Transforming pain target identification and therapeutic development.

Arrhythmogenic and antiarrhythmic actions of late sustained sodium current in the adult human heart.